These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2760211)

  • 1. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ; Ritter CR; Finch JL; Morrissey J; Martin KJ; Murayama E; Nishii Y; Slatopolsky E
    J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Nishii Y; Abe J; Mori T; Brown AJ; Dusso AS; Finch J; Lopez-Hilker S; Morrissey J; Slatopolsky E
    Contrib Nephrol; 1991; 91():123-8. PubMed ID: 1800003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
    J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
    Fan SL; Schroeder NJ; Calverley MJ; Burrin JM; Makin HL; Cunningham J
    Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
    Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H
    Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
    Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
    J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.
    Cantley LK; Russell J; Lettieri D; Sherwood LM
    Endocrinology; 1985 Nov; 117(5):2114-9. PubMed ID: 3840080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
    J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
    Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
    Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
    Russell J; Bar A; Sherwood LM; Hurwitz S
    Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathyroid cell culture.
    MacDonald PN; Ritter C; Brown AJ; Slatopolsky E
    J Clin Invest; 1994 Feb; 93(2):725-30. PubMed ID: 8113407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.